J. Goldman & Co LP - LARIMAR THERAPEUTICS INC ownership

LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 47 filers reported holding LARIMAR THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$213,300
+26.2%
54,0000.0%0.01%
+16.7%
Q2 2023$169,020
-69.3%
54,000
-55.6%
0.01%
-72.7%
Q1 2023$550,395
+229.6%
121,500
+962.0%
0.02%
+340.0%
Q1 2021$167,000
-89.2%
11,441
-84.2%
0.01%
-93.7%
Q4 2020$1,549,00072,3440.08%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 1,515,148$32,439,0009.14%
ACUTA CAPITAL PARTNERS, LLC 863,100$18,479,0005.03%
SILVERARC CAPITAL MANAGEMENT, LLC 217,203$4,650,0002.70%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,144,539$110,145,0002.18%
Atlas Venture Advisors, Inc. 292,184$6,256,0001.40%
Logos Global Management LP 715,000$15,308,0001.31%
Sio Capital Management, LLC 188,661$4,039,0000.83%
Vivo Capital, LLC 799,662$17,121,0000.76%
Altium Capital Management LP 93,261$1,997,0000.75%
RA Capital Management 1,515,151$32,439,0000.45%
View complete list of LARIMAR THERAPEUTICS INC shareholders